Qing Sarah Yuan
Direttore Tecnico/Scientifico/R&S presso SIGILON THERAPEUTICS, INC.
Profilo
Qing Sarah Yuan is currently the Chief Technical Operations Officer at Sigilon Therapeutics, Inc. Prior to this, she worked as the Head-Technical Development at Bioverativ, Inc. from 2017 to 2019.
She also held the position of Vice President-Process & Analytical Development at 2seventy Bio, Inc. Dr. Yuan holds a doctorate degree from the University of Wisconsin and an undergraduate degree from the University of California, Berkeley.
Posizioni attive di Qing Sarah Yuan
| Società | Posizione | Inizio |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 07/03/2022 |
Precedenti posizioni note di Qing Sarah Yuan
| Società | Posizione | Fine |
|---|---|---|
| BIOVERATIV INC | Corporate Officer/Principal | 01/01/2019 |
| 2SEVENTY BIO, INC. | Corporate Officer/Principal | - |
Formazione di Qing Sarah Yuan
| University of Wisconsin | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Qing Sarah Yuan
